Navigation Links
FDA Approves Erwinaze to Treat a Form of Leukemia
Date:11/18/2011

SILVER SPRING, Md., Nov. 18, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved Erwinaze (asparaginase Erwinia chrysanthemi) to treat patients with acute lymphoblastic leukemia (ALL), who have developed an allergy (hypersensitivity) to E. coli derived asparaginase and pegaspargase chemotherapy drugs used to treat ALL.

(Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO)

Acute lymphoblastic leukemia is a type of cancer in which the bone marrow makes too many lymphocytes, a type of white blood cell. White blood cells help the body fight infection and are formed in the bone marrow.

Erwinaze is injected directly into the muscle three times a week and works by breaking down one of the body's protein building blocks (the amino acid, asparagine) that is present in the blood, and is necessary for the growth of all cells. Leukemia cells cannot produce this protein building block. When a patient is treated with Erwinaze the leukemia cells die. Normal human cells are able to make enough asparagine for their own needs through biosynthesis and will not be affected by treatment with Erwinaze.

"The approval of Erwinaze underscores the FDA's commitment to the approval of drugs for conditions with limited patient populations with unmet medical needs using novel trial endpoints," said Richard Pazdur, M.D., director of the Office of Hematology and Oncology Products in the FDA's Center for Drug Evaluation and Research.

The safety and effectiveness of Erwinaze was evaluated in one clinical trial of 58 patients. Additional safety data was collected from the Erwinaze Master Treatment Protocol (EMTP), an expanded access program that enrolled 843 patients. Patients in both studies were unable to continue receiving pegaspargase or asparaginase derived from E. coli due to allergic reactions.

In the trial to suppo
'/>"/>

SOURCE U.S. Food and Drug Administration
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. FDA Approves New York Blood Centers HEMACORD™ for Stem Cell Transplantation
2. FDA Approves Erbitux to Treat Late-stage Head and Neck Cancer
3. FDA Approves Xarelto to Prevent Stroke in People With Common Type of Abnormal Heart Rhythm
4. FDA Approves U.S. Market Return for octagam® Following Octapharmas Implementation of Enhanced Safety Measures
5. FDA Approves First Artificial Aortic Heart Valve Placed Without Open-Heart Surgery
6. FDA Approves First Generic Olanzapine to Treat Schizophrenia, Bipolar Disorder
7. FDA Approves Onfi To Treat Severe Type of Seizures
8. FDA Approves Longer Duration Efficacy and Safety for EUFLEXXA®
9. FDA Approves Label Update for PREZISTA® to Include 192-Week Data in HIV-1-Infected Adult Patients Starting Treatment
10. FDA Approves Ferriprox to Treat Patients with Excess Iron in the Body
11. FDA Approves Combination Therapy Juvisync
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/30/2015)... Calif. , April 30, 2015  IRIDEX Corporation ... release its first quarter 2015 financial results after the ... In conjunction with the release, the Company will host ... 5:00 p.m. Eastern Time on Thursday, May ... quarter and other business developments. Interested parties ...
(Date:4/30/2015)...  Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX ) announced ... results after the market closes on Thursday, May 7, ... be held on Thursday, May 7, 2015, at 4:30 ... To participate in the call, please dial 877-303-1298 (for ... of the teleconference will be available for one week ...
(Date:4/30/2015)... Company plc (NYSE: PRGO ; TASE) today announced that Perrigo ... at the 2015 Deutsche Bank 40 th Annual Healthcare Conference ... Hotel in Boston , MA.  ... Joseph C. Papa will present at the Bank of America ... 12, 2015 at the Encore at Wynn Las Vegas Hotel in ...
Breaking Medicine Technology:IRIDEX Announces First Quarter 2015 Conference Call and Release Date 2Cumberland Pharmaceuticals To Announce First Quarter 2015 Financial Results 2Perrigo Company To Present At Upcoming Healthcare Conferences 2Perrigo Company To Present At Upcoming Healthcare Conferences 3
(Date:5/3/2015)... BolehVPN ” was featured on NewsWatch as part of its ... products available to consumers. Scott Steinberg, a technology expert and ... viewers how to protect their private information. , A lot ... even more so online. It helps everyone stay connected with ... In terms of work, the internet makes things more efficient. ...
(Date:5/3/2015)... MA (PRWEB) May 03, 2015 It is not ... Annual Brain Aneurysm Walk in Memory of Lissa Anne Been ... Lissa organized this great family-friendly event to honor her loving memory. ... its inception. , Just having turned 37, Lissa suffered a ... passed away on August 24, 2012. This event is designed to ...
(Date:5/2/2015)... BC (PRWEB) May 02, 2015 Vancouver fencing ... will now provide valuable advice to prospective clients related to ... are looking to install railings around their decks and patios. ... several questions that pop up once the person rolls up ... phases of installing a railing in finding a gate that ...
(Date:5/2/2015)... 2015 We are pleased to announce ... Center as one of the Top Workplaces of 2015. ... addiction treatment field for their ethics and standards of ... to continue their educational efforts. The Delray Recovery Center ... forgetting their purpose – to help individuals heal from ...
(Date:5/2/2015)... TX (PRWEB) May 02, 2015 ... skin laxity issues of the face, neck and ... new concept with real potential for the success ... by the ThermiHealth Clinical Advisory Council, ThermiGyn’s Women’s ... FACOG, FACS, ACGE, concluded that ThermiGyn’s temperature controlled ...
Breaking Medicine News(10 mins):Health News:A Method to Keep Private Information Secure was Featured on NewsWatch Television 2Health News:Renowned Brain Aneurysm Foundation to Benefit from Arnold, Missouri’s 3rd Annual Brain Aneurysm Walk in Memory of Lissa Anne Been 2Health News:Professional Staff at QS Fencing Company Now Provides Advice on Railings and Gates 2Health News:The Delray Recovery Center Named 2015 Top Workplace 2Health News:Study Demonstrates Efficacy of Temperature Controlled Radiofrequency for Vulvovaginal Laxity 2Health News:Study Demonstrates Efficacy of Temperature Controlled Radiofrequency for Vulvovaginal Laxity 3
... , THURSDAY, March 15 (HealthDay News) -- Eating ... in fried foods, baked goods and other prepared meals and ... -- behavior, new research suggests. In conducting the study, ... Medicine analyzed the diet and behavior of 945 men and ...
... DENVER Patients with early stage malignant pleural mesothelioma ... the lungs, may be eligible for aggressive multi-modality therapy ... approaches, and controversy has existed about which approach is ... extensive surgery where surgeons remove the entire diseased lung, ...
... in the gym, surrounded by others, pounding to the beat in ... when it comes to the experience of changing in the locker ... front of others, can be very discomfiting. It,s a complex experience ... than in any other space. "I walk into the change ...
... alcohol consumption has been consistently associated with lower risk ... certain, especially among women. A total of 83,578 ... free of diagnosed cardiovascular disease and cancer at baseline ... alcohol consumption were assessed at baseline and updated approximately ...
... there is a clear relationship between androgenetic alopecia (common ... enlargement of the prostate that appears in aging men ... condition appears in 50% of men over 60 year ... In the light of the study published in the ...
... A 21,626-person study published today in the Journal ... rate for children and adolescents with acute lymphoblastic leukemia ... percent in those diagnosed during the years 1990-1994, to ... "The improved survival is due to using existing ...
Cached Medicine News:Health News:Could Trans Fats Make You Cranky? 2Health News:Pleurectomy/decortication proposed preferred surgical procedure 2Health News:The stress of undress 2Health News:The stress of undress 3Health News:Moderate drinking associated with lower risk of stroke in women 2Health News:A study confirms the correlation between premature alopecia and prostate conditions 2Health News:Largest ever study of childhood ALL shows improving survival 2
... tiny, water-resistant monitor captures the data you ... ,Requiring only five electrodes, the DigiTrak ... the entire patient test, which can be ... AA battery. Three channels of ECG recording ...
... biograph 6 offers the ultimate ... diagnosis and treatment in oncology, ... high-quality PET/CT whole body scans ... Our comprehensive suite of clinical ...
... Lunar DPX Duo is a SmartBeam platform ... get measurements of the two most clinical ... seconds, and at a low radiation dose., ... based on Windows, optimizes productivity and ensures ...
... ScImage's PICOMEnterprise is a web-enabled ... custom reporting and custom workflow integration. ... captures, stores, distributes and archives images, ... any DICOM and many non-DICOM devices ...
Medicine Products: